000 01672 a2200445 4500
005 20250517032000.0
264 0 _c20160321
008 201603s 0 0 eng d
022 _a1791-2423
024 7 _a10.3892/ijo.2015.2982
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYi, Yong Weon
245 0 0 _aDual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6.
_h[electronic resource]
260 _bInternational journal of oncology
_cJul 2015
300 _a122-32 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDown-Regulation
650 0 4 _aDrug Synergism
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aFemale
650 0 4 _aGefitinib
650 0 4 _aHumans
650 0 4 _aIndoles
_xpharmacology
650 0 4 _aPeptide Library
650 0 4 _aPiperazines
_xpharmacology
650 0 4 _aProto-Oncogene Proteins c-met
_xantagonists & inhibitors
650 0 4 _aQuinazolines
_xpharmacology
650 0 4 _aRibosomal Protein S6
_xmetabolism
650 0 4 _aSulfonamides
_xpharmacology
650 0 4 _aTriple Negative Breast Neoplasms
_xdrug therapy
700 1 _aYou, Kyusic
700 1 _aBae, Edward Jeong
700 1 _aKwak, Sahng-June
700 1 _aSeong, Yeon-Sun
700 1 _aBae, Insoo
773 0 _tInternational journal of oncology
_gvol. 47
_gno. 1
_gp. 122-32
856 4 0 _uhttps://doi.org/10.3892/ijo.2015.2982
_zAvailable from publisher's website
999 _c24882685
_d24882685